The second study was a prospective cohort study of 19 patients in which D'Egidio et al. [12] followed patients from Ottawa, Canada with CD4 counts having plateaued at <200 cells/μL and undetectable VL while off PCP prophylaxis. Here, CD4 is linked to pneumocystosis.